2 min read

FT1000 2026: Fastest-growing medical device software company in Europe

Revolve Healthcare has been listed in the FT1000: Europe’s Fastest-Growing Companies 2026, published by the Financial Times in partnership with Statista. The ranking, released today on FT.com, recognises organisations that have achieved outstanding revenue growth across Europe. As a fastest-growing medical device software company in Europe, Revolve Healthcare is recognised for its continued expansion within the highly regulated healthcare and medical technology sector.

The 2026 FT1000 edition features companies that are scaling successfully in competitive markets, including healthcare, life sciences, and digital health.

Recognition by the Financial Times and Statista

The FT1000: Europe’s Fastest-Growing Companies ranking is compiled annually by the Financial Times and Statista using independently verified financial data. The early ranking is now available on FT.com, with full editorial coverage scheduled for later this month as part of a dedicated Special Report.

Inclusion in the FT1000 2026 places Revolve Healthcare among a select group of Europe’s fastest-growing companies recognised by a leading global business publication.

Growth built on medical device software expertise

Revolve Healthcare operates as a medical device software development company, delivering custom software solutions for organisations developing regulated medical products. Our work supports companies building medical device software and Software as a Medical Device (SaMD) solutions that must meet strict regulatory, security, and quality requirements.

This recognition reflects growth driven by long-term partnerships with healthcare and medical device organisations seeking specialised software expertise rather than generic technology services.

What this means for our clients and partners

Being included in the FT1000 2026 ranking demonstrates sustainable growth and operational maturity. For clients and partners, it confirms that Revolve Healthcare is a reliable software development partner capable of scaling while maintaining the standards required in regulated healthcare environments.

Our growth has been shaped by collaboration with organisations that require tailored, compliant software designed for real-world clinical use.

Looking ahead

As we continue to expand our footprint across Europe, Revolve Healthcare remains focused on supporting medical device and healthcare companies with custom software built for evolving regulatory and technological demands.

We thank our clients, partners, and team members whose trust and collaboration have contributed to this recognition.

FAQ

What is the FT1000 ranking?

The FT1000 is an annual ranking published by the Financial Times and Statista that identifies Europe’s fastest-growing companies based on verified revenue growth.

Why was Revolve Healthcare included in the FT1000 2026?

Revolve Healthcare met the growth criteria defined by the Financial Times and Statista and was recognised for its sustained business growth as a medical device software development company in Europe.

Does the FT1000 ranking focus on healthcare companies?

The FT1000 includes companies from multiple industries. Revolve Healthcare’s inclusion reflects growth within the specialised field of medical device and healthcare software.

What does this recognition mean for Revolve Healthcare’s clients?

The ranking signals that clients are working with a fast-growing, stable, and experienced partner capable of delivering compliant medical device software at scale.

Revolve Healthcare is a European medical device software development company providing custom, regulated software for medical technology and healthcare organisations.

Explore how we support

medical device companies with custom regulated software

Category:

You may also like